A domestic study has demonstrated the effect of deoxycholic acid (DCA), the main component of fat-destroying injections, on ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

First-generation GLP-1 drugs have found to cut down the risk of obesity-related cancers by 41%, outperforming weight-loss ...

You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...

Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1 ...

PEOPLE regain the weight they lose on fat jabs within two years of stopping the drugs, research suggests. Ozempic-style ...

Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) ...

"The Agency agrees that the 'reduction of abdominal subcutaneous fat' as the proposed indication reinforces our confidence in CBL-514's differentiated value, and its potential to redefine ...